Physician profile
Nicole Tracy Tasker
NPI 1649781204
$125,464.13
in general payments reported to CMS, 2019-2025
14 companies · $5,400 in 2025
The $5,400 reported for 2025 was more than what 99% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41K · 2022: $26K · 2023: $31K · 2024: $22K · 2025: $5,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Travel and Lodging: $18K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,785 · Food and Beverage: $4,595 · Consulting Fee: $2,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,740.00 |
| Travel and Lodging | $17,913.99 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,784.78 |
| Food and Beverage | $4,594.64 |
| Consulting Fee | $2,538.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $85,214.53 | 2021-2025 | Lynparza, Enhertu |
| Eisai INC. | $26,532.81 | 2021-2025 | |
| Abbvie INC. | $6,029.97 | 2024-2025 | |
| Immunogen, INC. | $5,211.29 | 2023 | Elahere |
| Foundation Medicine, INC. | $801.13 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $520.45 | 2021-2025 | Keytruda, Lynparza |
| Clovis Oncology, INC. | $444.71 | 2021-2022 | |
| Coherus Oncology, INC. | $243.36 | 2021-2022 | |
| Seagen INC. | $163.91 | 2023 | |
| Servier Pharmaceuticals LLC | $121.00 | 2023 | |
| Myriad Genetic Laboratories, INC. | $102.36 | 2021-2024 | Mychoice Cdx |
| Lilly USA, LLC | $29.80 | 2022 | |
| Genentech USA, INC. | $29.08 | 2025 | Itovebi |
| Amgen INC. | $19.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Tasker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.